BioPharma Dive - Latest News

Novartis to acquire Regulus in deal for kidney disease drug

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance microRNA technology.

Apr 30, 2025 - 17:35
 0
Novartis to acquire Regulus in deal for kidney disease drug

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance microRNA technology.

Read More

Tags:

Previous Article

Exemplary drivers: Spain, Portugal, South of France drivers prioritize safety du...

Next Article

Winners announced for Autocar Great Women: Rising Stars 2025

Related Posts

BridgeBio sales of new heart drug outstrip expectations

BridgeBio sales of new heart drug outstrip expectations

Apr 30, 2025  0

Merck takes $200M tariff hit, trimming its gross profits

Merck takes $200M tariff hit, trimming its gross profits

Apr 24, 2025  0

Bristol Myers says schizophrenia drug launch ‘off to a solid start’

Bristol Myers says schizophrenia drug launch ‘off to a ...

Apr 24, 2025  0